DAVOS,Switzerland,Jan. 23,2025--Tech Mahindra (NSE: TECHM),a leading global provider of technology consulting and digital solutions to enterprises across industries,has partnered with the Wall Street
TOKYO,Jan. 24,2025-- Recently,Automotive World 2025,the world\'s leading exhibition for advanced automotive technologies,was successfully held in Tokyo,Japan. Neusoft Corporation (Neusoft,SSE:600718)
Company Anticipates Return to Growth in 2025
SHANGHAI,Jan. 24,2025-- Nisun International Enterprise Development Group Co.,Ltd ("Nisun International" or the "Company") (Nasdaq: NISN
01-26 Nisun International Enterprise Development Group Co., Ltd.
SINGAPORE,Jan. 20,2025--Twenty-five years ago,Singapore Management University (SMU) started out as a bold experiment in transforming the higher education in Singapore. Today,it has already gained the
BALI,Indonesia,Jan. 20,2025-- XCION,a leading CXO community platform in Indonesia,is back to hold their highly anticipated annual conference and exhibition in Indonesia for the 12th year running. XCI
HONG KONG,Jan. 20,2025-- On January 16,2025,WeBank Technology Services ("the Company") marked a key milestone inits global expansion with its inauguralceremony in Hong Kong.The event was att
KHORGOS,Kazakhstan,Jan. 20,2025-- January 17,last Friday,marked the groundbreaking of Envision Energy\'s renewable energy plant in Kazakhstan,a key project for the company\'s global presence in clean
On the first Wednesday of every month since 2005, rain or shine, a determined circle forms outside Osaka Station. Holding portraits of silver-haired women and signs reading "Let us build a society together where peace and human rights prevail, preserving the memory of history," members of a Japanese civil group raise voices that Tokyo has long tried to silence.
On the early morning of May 12, a 5.5-magnitude earthquake struck Lhaze county, Xigaze, Southwest China's Xizang Autonomous Region. The earthquake had a focal depth of 10 kilometers and affected surrounding areas, including Saga county.
Taipei-based biotech company Jyong Biotech Ltd. has leveraged a successful IPO to accelerate the development of MCS-2, a promising treatment for benign prostatic hyperplasia (BPH).